Venture Investors

Venture Investors seeks the next big things in healthcare. Based in the Midwest with open access to renowned research universities, and the vibrant communities that surround them, we target, uncover, and invest in extraordinary ideas that will shape the future of health and wellness. With decades of proven success, we’re fueling the future of what’s driving healthcare.

Venture Investors favicon
Founded 1982 · Venture Capital
Madison (United States), Ann Arbor (United States), Milwaukee (United States)
Investment Stages
Pre-Seed
Seed
Series A
Markets
Pharma
Diagnostics
Devices & Digital Health
Portfolio Companies

Aerpio Pharmaceuticals, Akebia Therapeutics, BlueWillow Biologics, Cellectar Biosciences, Inc., Delphinus Medical Technologies, Deltanoid Pharmaceuticals, Dvant Pharma, EarliTec Diagnostics, Elephas, Elucent Medical, EnsoData, Euthymics Bioscience, Eximis Surgical, FluGen, Gala, GDXI, HealthMyne, HistoSonics, Intralase, Invenra, Inviragen, Iterion Therapeutics, LenSx, Nerites, NeuMoDx, Neurovance, NeuWave Medical, NimbleGen Systems, Promega, Rivermark Medical, TAI Diagnostics, ThirdWave Molecular Diagnostics, Tissue Regeneration Systems, TomoTherapy, ViaLase, Visana Health, Zystor

Share this page

Want more backlinks, traffic, and startup visibility?

Get your startup listed in 100+ directories automatically. Perfect for SaaS, AI, and tech startups.

Submit Your Startup